Rocket Pharmaceuticals
RCKT
RCKT
164 hedge funds and large institutions have $1.52B invested in Rocket Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 17
1% more funds holding
Funds holding: 163 → 164 (+1)
3.73% less ownership
Funds ownership: 98.63% → 94.9% (-3.7%)
Holders
164
Holding in Top 10
4
Calls
$4.54M
Puts
$1.03M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$8.34M | |
| 3 | +$5.97M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$4.74M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$16.7M | |
| 3 | -$12.9M | |
| 4 |
BlackRock
New York
|
-$6.58M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5.59M |